Drug class
Thioxanthene antipsychotic; dopamine D2 receptor antagonist
Mechanism of action
Antagonises central dopamine D2 receptors and also interacts with other monoamine receptors, reducing dopaminergic signalling associated with psychosis. Low-dose and depot formulations have different clinical uses and duration.
General use cases
- Treatment of schizophrenia and other psychotic disorders with oral or depot formulations in countries where authorised
- Low-dose oral flupentixol has been used for depressive or anxiety symptoms in some jurisdictions, but these indications are not universal and should be assigned only to the specific authorised product
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
